Archived Facts

Novartis AG is bracing for lower profitability this year as key products like top-selling blood pressure drug Diovan face competition from cheaper rivals, the Swiss drugmaker said as it posted an 8 percent rise in quarterly earnings.

Popular Posts:

Related Posts:

Leave a Reply